These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 12708902
1. Investigations of the immunoglobulin subtype transformation of anti-heparin-platelet factor 4 antibodies during treatment with a low-molecular-weight heparin (clivarin) in orthopedic patients. Ahmad S, Bacher HP, Lassen MR, Hoppensteadt DA, Leitz H, Misselwitz F, Walenga JM, Fareed J. Arch Pathol Lab Med; 2003 May; 127(5):584-8. PubMed ID: 12708902 [Abstract] [Full Text] [Related]
4. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG. Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J. Thromb Res; 2002 Jan 15; 105(2):117-23. PubMed ID: 11958801 [Abstract] [Full Text] [Related]
5. Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies. Untch B, Ahmad S, Messmore HL, Schultz CL, Ma Q, Hoppensteadt DA, Walenga JM, Fareed J. Thromb Res; 2002 Apr 15; 106(2):149-56. PubMed ID: 12182915 [Abstract] [Full Text] [Related]
8. Anti-PF4-heparin immunoglobulin G is the major class of heparin-induced thrombocytopenia antibody: findings of an enzyme-linked immunofiltration assay using membrane-bound hPF4-heparin. Vun CM, Evans S, Chesterman CN. Br J Haematol; 2001 Jan 15; 112(1):69-75. PubMed ID: 11167786 [Abstract] [Full Text] [Related]
9. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. J Lab Clin Med; 2005 Dec 15; 146(6):341-6. PubMed ID: 16310517 [Abstract] [Full Text] [Related]
17. Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin. Adiguzel C, Bansal V, Litinas E, Cunanan J, Iqbal O, Nelson K, Kannan M, Hoppensteadt D, Fareed J. Clin Appl Thromb Hemost; 2009 Aug 15; 15(2):145-51. PubMed ID: 19357103 [Abstract] [Full Text] [Related]